Meng‐Tzu Weng

机构：National Taiwan University Hospital · ORCID：0000-0002-4143-6607

发表论文 128 篇 · 总被引 1748 次 · h-index 24

代表论文

• Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial (2024 · Hepatology International · 被引 13)
• Thermo- and pH-responsive MOF-303 mediated P127 and Gelatin coating for combination drug release and liver cancer therapy (2025 · Materials Today Chemistry · 被引 11)
• Ethanol inhibits the growth and metastasis of hepatocellular carcinoma by inducing immunogenic cell death (2025 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study Across Asia (2025 · Clinical Gastroenterology and Hepatology · 被引 4)
• HLA-C *03:04:01 and HLA-B *15:18:01 but not HLA-DQA1 *05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients (2025 · World Journal of Gastroenterology · 被引 3)
• Novel Naphthyridones Targeting Pannexin 1 for Colitis Management (2024 · Advanced Science · 被引 3)